Net Cash Provided by (Used in) Operating Activities |
-17.8K |
USD |
-8.21% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
17.8K |
USD |
+8.21% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
500M |
shares |
0% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares, Issued |
27.8M |
shares |
0% |
Q1 2025 |
Q1 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
0 |
USD |
|
Q1 2025 |
Q1 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
179K |
USD |
+9.35% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
179K |
USD |
+9.35% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
853K |
USD |
+9.35% |
Q4 2024 |
FY 2024 |
Additional Paid in Capital |
0 |
USD |
|
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2024 |
FY 2024 |
Interest Expense |
36.3K |
USD |
-0.27% |
Q1 2025 |
Q1 2025 |